Corvus Pharma Historical PE Ratio image   This CRVS PE ratio history page last updated 5/8/2024
Corvus Pharma Historical PE Ratio Chart
PeriodPriceGAAPAnnualizedPE
Q1 2024
5/6/2024
1.91-0.12-0.48NA
Q4 2023
3/19/2024
1.96-0.14-0.56NA
Q3 2023
11/7/2023
1.58-0.12-0.48NA
Q2 2023
8/8/2023
2.14-0.14-0.56NA
Q1 2023
5/8/2023
1.30-0.17-0.68NA
Q4 2022
3/28/2023
0.65-0.21-0.84NA
Q3 2022
11/3/2022
0.86-0.32-1.28NA
Q2 2022
8/8/2022
0.96-0.18-0.72NA
Q1 2022
5/5/2022
1.33-0.18-0.72NA
Q4 2021
3/10/2022
1.59-0.20-0.80NA
Q3 2021
11/1/2021
4.83-0.24-0.96NA
Q2 2021
8/2/2021
2.14-0.28-1.12NA
Q1 2021
4/29/2021
2.82-0.34-1.36NA
Q4 2020
3/25/2021
3.12-0.34-1.36NA
Q3 2020
10/29/2020
3.99-0.33-1.32NA
Q2 2020
7/30/2020
4.27-0.36-1.44NA
Q1 2020
4/30/2020
2.43-0.44-1.76NA
Q4 2019
3/5/2020
3.59-0.38-1.52NA
Q3 2019
10/29/2019
3.54-0.37-1.48NA
Q2 2019
8/1/2019
3.83-0.44-1.76NA
Q1 2019
5/9/2019
4.11-0.40-1.60NA
Q4 2018
3/7/2019
4.18-0.36-1.44NA
Q3 2018
11/1/2018
8.20-0.36-1.44NA
Q2 2018
8/2/2018
9.42-0.40-1.60NA
Q1 2018
5/3/2018
9.42-0.63-2.52NA
Q4 2017
3/1/2018
7.82-0.58-2.32NA
Q3 2017
11/2/2017
14.42-0.62-2.48NA
Q2 2017
8/3/2017
12.07-0.73-2.92NA
Q1 2017
5/4/2017
9.74-0.79-3.16NA
Q4 2016
3/10/2017
17.46-0.55-2.20NA
Q3 2016
11/3/2016
13.63-0.51-2.04NA
Q2 2016
8/4/2016
13.16-0.43-1.72NA
Q1 2016
5/5/2016
12.42-5.39-21.56NA
Corvus Pharma PE History Chart
PeriodPriceGAAPTTMPE
Q1 2024
5/6/2024
1.91-0.12-0.52NA
Q4 2023
3/19/2024
1.96-0.14-0.57NA
Q3 2023
11/7/2023
1.58-0.12-0.64NA
Q2 2023
8/8/2023
2.14-0.14-0.84NA
Q1 2023
5/8/2023
1.30-0.17-0.88NA
Q4 2022
3/28/2023
0.65-0.21-0.89NA
Q3 2022
11/3/2022
0.86-0.32-0.88NA
Q2 2022
8/8/2022
0.96-0.18-0.80NA
Q1 2022
5/5/2022
1.33-0.18-0.90NA
Q4 2021
3/10/2022
1.59-0.20-1.06NA
Q3 2021
11/1/2021
4.83-0.24-1.20NA
Q2 2021
8/2/2021
2.14-0.28-1.29NA
Q1 2021
4/29/2021
2.82-0.34-1.37NA
Q4 2020
3/25/2021
3.12-0.34-1.47NA
Q3 2020
10/29/2020
3.99-0.33-1.51NA
Q2 2020
7/30/2020
4.27-0.36-1.55NA
Q1 2020
4/30/2020
2.43-0.44-1.63NA
Q4 2019
3/5/2020
3.59-0.38-1.59NA
Q3 2019
10/29/2019
3.54-0.37-1.57NA
Q2 2019
8/1/2019
3.83-0.44-1.56NA
Q1 2019
5/9/2019
4.11-0.40-1.52NA
Q4 2018
3/7/2019
4.18-0.36-1.75NA
Q3 2018
11/1/2018
8.20-0.36-1.97NA
Q2 2018
8/2/2018
9.42-0.40-2.23NA
Q1 2018
5/3/2018
9.42-0.63-2.56NA
Q4 2017
3/1/2018
7.82-0.58-2.72NA
Q3 2017
11/2/2017
14.42-0.62-2.69NA
Q2 2017
8/3/2017
12.07-0.73-2.58NA
Q1 2017
5/4/2017
9.74-0.79-2.28NA
Q4 2016
3/10/2017
17.46-0.55-6.88NA
Q3 2016
11/3/2016
13.63-0.51NANA
Q2 2016
8/4/2016
13.16-0.43NANA
Q1 2016
5/5/2016
12.42-5.39NANA
Quotes delayed 20 minutes

Email EnvelopeFree CRVS Email Alerts:
Get Dividend Alerts
Get SEC Filing Alerts
10 Most Oversold S&P 500 Stocks
10 Most Overbought S&P 500 Stocks
10 ETFs With Stocks Insiders Are Buying
10 ETFs With Most Upside To Targets
The DividendRank Top 25
Warren Buffett Dividend Stocks
10 Cheap Dividend Stocks Under $10
10 Top DividendRank'ed Energy Stocks
The 10 Highest Yielding Preferred Stocks
The 10 Highest Yielding Preferred Stocks
The 15 Most Active S&P Call & Put Options
Corvus Pharma (CRVS) is categorized under the Healthcare sector; to help you further research PE history across stocks, below are some other companies in the same sector:

CRY PE Ratio History
CSBR PE Ratio History
CSII PE Ratio History
CSTL PE Ratio History
CSU PE Ratio History
CTIC PE Ratio History
CTKB PE Ratio History
CTLT PE Ratio History
CTMX PE Ratio History
CTSO PE Ratio History
How should the CRVS historical PE ratio be determined?
Realizing that PE stands for Price to Earnings ratio, we need two values to compute it: stock price and earnings per share. The stock price at any given date is a known historical value, but what about the earnings number to use?

✔️Accepted answer: There are a number of different approaches when it comes to calculating a historical PE ratio for a company like Corvus Pharma. We like to take our measurements on each of the past quarterly earnings reports. That only leaves the question of whether the earnings number at that quarterly report should be used on an annualized basis, or some other method. We approach this question using three different methods, on this CRVS Historical PE Ratio page.

What is the average historical PE for CRVS based on annualized quarterly earnings?
As we look back through earnings history, what is the resulting PE calculation if at each measurement period we use that quarter's earnings result annualized?

✔️Accepted answer: The CRVS historical PE ratio using the annualized quarterly earnings method works out to NA.

What is the average historical PE for CRVS based on trailing twelve month earnings?
As we look back through earnings history, what is the resulting PE calculation if at each measurement period we use the trailing twelve months combined earnings result in the calculation?

✔️Accepted answer: The CRVS historical PE ratio using the TTM earnings method works out to NA.

On this page we presented the Corvus Pharma Historical PE Ratio information for Corvus Pharma' stock. The average CRVS historical PE based on using the annualized quarterly earnings result at each measurement period (for the "E" in the PE calculation; and the closing price on earnings date as the "P") is NA. Meanwhile, using the trailing twelve month (TTM) quarterly earnings result as our method of calculation the "E" value at each measurement period, the average CRVS historical PE based on this TTM earnings result method is NA. Note: any PE calculations involving negative earnings were discarded as not meaningful.

Let's now compare this CRVS historical PE result, against the recent PE: when this page was posted on 5/7/2024, the most recent closing price for CRVS had been 1.68, and the most recent quarterly earnings result, annualized, was NA. Meanwhile, the most recent TTM earnings summed to NA.

For self directed investors doing their due diligence on CRVS or any other given stock, valuation analysis for CRVS can greatly benefit from studying the past earnings and resulting PE calculations. This exercise can help inform an analysis as to whether the past earnings trajectory and current versus historical PE ratios justify the current stock value.

That's why we bring you HistoricalPERatio.com to make it easy for investors to investigate Corvus Pharma PE history or the past PE information for any stock in our coverage universe. And in your continued research we hope you will be sure to check out the further links included for earnings surprises history (beat/miss data) as well as next earnings dates for CRVS. Thanks for visiting, and the next time you need to research CRVS Historical PE Ratio or the ratio for another stock, we hope you'll think of our site, as your go-to historical PE ratio research resource of choice.

Recommended: GMW Videos, Top Ten Hedge Funds Holding XBAP, ETFs Holding MANU.

 

Corvus Pharma Historical PE Ratio | www.HistoricalPERatio.com | Copyright © 2020 - 2024, All Rights Reserved

Nothing in HistoricalPERatio.com is intended to be investment advice, nor does it represent the opinion of, counsel from, or recommendations by BNK Invest Inc. or any of its affiliates, subsidiaries or partners. None of the information contained herein constitutes a recommendation that any particular security, portfolio, transaction, or investment strategy is suitable for any specific person. All viewers agree that under no circumstances will BNK Invest, Inc,. its subsidiaries, partners, officers, employees, affiliates, or agents be held liable for any loss or damage caused by your reliance on information obtained. By visiting, using or viewing this site, you agree to the following Full Disclaimer & Terms of Use and Privacy Policy. Video widget and market videos powered by Market News Video. Quote and option data delayed at least 15 minutes; stock quote data powered by Ticker Technologies, and Mergent.
X
Wait! Don't leave yet.
Want to receive our latest research absolutely free?


Click the button below for your complimentary copy of Your Early Retirement Portfolio: Dividends Up to 8.7%—Every Month—Forever.

You'll discover the details on 4 stocks and funds that pay you massive dividends as high as 8.7%.